Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jorge-Luis Poo"'
Autor:
Eira Cerda Reyes, Ricardo De la Rosa Bibiano, Ana Sandoval Rodriguez, Rebeca Rosas Campos, Rebeca Escutia Gutiérrez, Ángel Omar Vázquez Esqueda, Stefanny Cornejo Hernández, Alejandro Gutiérrez Átemis, Salvador Amezquita Pérez, Jorge Luis Poo, Gildardo Agustin Garrio Sanchez, Juan Ramón Aguilar, Juan Armendáriz Borunda
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101640- (2024)
Conflict of interest: No Introduction and Objectives: Patients with residual liver fibrosis following the eradication of hepatitis C virus (HCV) represent a significant clinical challenge due to the continuous risk of disease progression and the deve
Externí odkaz:
https://doaj.org/article/13afaa1df14d490d9f73eb92e24465b6
Autor:
Linda E. Munoz-Espinosa, Aldo Torre, Laura Cisneros, Iaarah Montalvo-Gordon, René Malé-Velázquez, Scherezada Mejía, Juan Ramón Aguilar-Ramírez, Javier Lizardi-Cervera, María E. Icaza-Chávez, Frida Gasca-Díaz, Larissa Hernández-Hernández, Paula Cordero-Perez, Luis A. Chi-Cervera, Lilian Torres-Made, Fátima Rodríguez-Álvarez, Graciela Tapia, Jorge Luis Poo
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101472- (2024)
Introduction and Objectives: Advanced liver fibrosis (ALF) is a predictor of adverse prognosis in chronic liver disease. In addition to etiological treatment, a new approach to stop or reverse residual fibrosis would be desirable. Our aim was to asse
Externí odkaz:
https://doaj.org/article/e2f802b259ad4644b6abcff4efec9996
Autor:
Javier Lizardi-Cervera, Jorge Luis Poo, Karla Romero-Mora, Beatriz Castañeda, Raúl Pichardo-Bahena, Segundo Morán, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 5, Iss 4, Pp 257-262 (2006)
The role of hepatitis C virus (HCV) is well established in the development of chronic hepatitis, cirrhosis and hepatic carcinoma, as well as in mixed type II cryoglobulinemia, membranoproliferative glomerulonephritis (MPGN) and porphyria cutanea tard
Externí odkaz:
https://doaj.org/article/5f5edd07cac7453b9b6ce52977bd7be3
Autor:
Jorge Luis Poo, Julieta Góngora, Francisco Sánchez-Ávila, Sergio Aguilar-Castillo, Guillermo García-Ramos, Mario Fernández-Zertuche, Lourdes Rodríguez-Fragoso, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 5, Iss 4, Pp 281-288 (2006)
Despite steady progress in therapeutics of liver disease, portal systemic encephalopathy remains to be a great challenge for clinicians because of the heterogeneity of neuropsychiatric symptoms, multiple risk factors and complexity on achieving a sus
Externí odkaz:
https://doaj.org/article/7d12bb37e95c44f1aa1098d3bba86607
Publikováno v:
Annals of Hepatology, Vol 4, Iss 3, Pp 188-191 (2005)
Objective: To evaluate the frequency of hepatobiliary diseases and the clinical manifestations in patients with HIV treated with non highly active anti-retroviral therapy. Methods: Seven hundred clinical records of patients with HIV infection who ent
Externí odkaz:
https://doaj.org/article/4518be69d9a240739351a460110ba9b3
Autor:
Jorge Luis Poo, Julieta Gongora
Publikováno v:
Annals of Hepatology, Vol 5, Iss 3, Pp 224-226 (2006)
Hepatic perforation is an unusual complication of woman pregnancy associated with a poor outcome. A comprehensive review of epidemiology, clinical spectrum, diagnostic methods and therapeutic options is presented in this short paper.
Externí odkaz:
https://doaj.org/article/cd82ca04d6b64978a471d45b705f00d4
Autor:
Angélica Patiño, Frida Gasca, Laura Cisneros, Graciela Tapia, Carlos Ramírez-Castillo, Francisco J. Flores-Murrieta, Juan Ramón Aguilar-Ramírez, Eira Cerda, Luis Mejía-Cuán, Jorge Luis Poo, Mauricio Cruz, Linda E. Muñoz-Espinosa, Samuel Treviño, Larissa Hernández, Aldo Torre, Francisco Bosques-Padilla, Alfredo Velázquez, Juan Armendáriz-Borunda
Publikováno v:
Hepatology International
Background and aims Pirfenidone (PFD), an oral antifibrotic drug, has been authorized by the EMA and FDA for treatment of idiopathic pulmonary fibrosis. Few studies have addressed its use in advanced liver fibrosis (ALF). We evaluated a prolonged-rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eddac2e0c83aacf0a8e7a572d7ad1e7
https://pubmed.ncbi.nlm.nih.gov/32813194
https://pubmed.ncbi.nlm.nih.gov/32813194
Publikováno v:
Annals of Hepatology, Vol 10, Iss , Pp S55-S59 (2011)
Hyperammonemia and associated cerebral edema cause neurological abnormalities in liver disease patients. Although only 15% of ammonia production originates in the colon, management strategies for hepatic encephalopathy (HE) have focused on reducing a
Externí odkaz:
https://doaj.org/article/5b121c72083a4b3a9b71b722a697cd84
Autor:
Salvador Namur, Victoria Burke-Fraga, Juan Francisco Galan-Herrera, Elvira Fuentes-Fuentes, Mario González-de la Parra, Oscar Rosales-Sanchez, Lizbeth Cariño, Jorge Luis Poo
Publikováno v:
Clinical Therapeutics. 31:1796-1803
Background: Levofloxacin is a synthetic fluoroquinolone with a broad spectrum of antibacterial activity. It is indicated for the treatment of respiratory, sinus, skin, and urinary tract infections. Although generic formulations of oral levofloxacin a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d855f6ed8f4518c824ff728cc01b5bd6
https://doi.org/10.1016/j.clinthera.2009.08.004
https://doi.org/10.1016/j.clinthera.2009.08.004
Autor:
Jorge Luis Poo, X. Garcia-Samper, Francisco Sanchez-Avila, Misael Uribe, Julieta Góngora, David Kershenobich
Publikováno v:
Journal of Gastroenterology and Hepatology. 19:S79-S81
Despite steady progress in antiviral treatment for patients with chronic hepatitis C virus (HCV), many patients still have detectable serum HCV RNA levels by the end of interferon-based treatment and are known as virological non-responders. Re-treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed246dd1cf80bc72fc5f757eaea5a4e
https://doi.org/10.1111/j.1440-1746.2004.03634.x
https://doi.org/10.1111/j.1440-1746.2004.03634.x